Becton, Dickinson and Company
Becton, Dickinson and Company (BDXA) Financial Performance & Income Statement Overview
Analyze Becton, Dickinson and Company (BDXA) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Becton, Dickinson and Company (BDXA) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Becton, Dickinson and Company BDXA financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.17B | $5.44B | $4.99B | $5.04B |
| Cost of Revenue | $2.93B | $2.95B | $2.68B | $2.74B |
| Gross Profit | $2.23B | $2.49B | $2.31B | $2.30B |
| Gross Profit Ratio | $0.43 | $0.46 | $0.46 | $0.46 |
| R&D Expenses | $343.00M | $302.00M | $299.00M | $299.00M |
| SG&A Expenses | $1.32B | $1.26B | $1.20B | $1.19B |
| Operating Expenses | $1.78B | $1.86B | $1.59B | $1.47B |
| Total Costs & Expenses | $4.71B | $4.62B | $4.28B | $4.21B |
| Interest Income | $23.00M | $55.00M | $48.00M | $26.00M |
| Interest Expense | $155.00M | $155.00M | $137.00M | $125.00M |
| Depreciation & Amortization | $0.00 | $47.00M | $568.00M | $571.00M |
| EBITDA | $453.00M | $697.00M | $1.21B | $1.33B |
| EBITDA Ratio | $0.09 | $0.13 | $0.26 | $0.28 |
| Operating Income | $453.00M | $650.00M | $715.00M | $835.00M |
| Operating Income Ratio | $0.09 | $0.12 | $0.14 | $0.17 |
| Other Income/Expenses (Net) | -$147.00M | -$136.00M | -$215.00M | -$101.00M |
| Income Before Tax | $306.00M | $514.00M | $500.00M | $633.00M |
| Income Before Tax Ratio | $0.06 | $0.09 | $0.10 | $0.13 |
| Income Tax Expense | $3.00M | $114.00M | $13.00M | $96.00M |
| Net Income | $303.00M | $400.00M | $487.00M | $537.00M |
| Net Income Ratio | $0.06 | $0.07 | $0.10 | $0.11 |
| EPS | $1.05 | -$4.51 | $1.68 | $1.85 |
| Diluted EPS | $1.04 | -$4.49 | $1.68 | $1.85 |
| Weighted Avg Shares Outstanding | $289.50M | $289.61M | $289.56M | $289.52M |
| Weighted Avg Shares Outstanding (Diluted) | $290.39M | $290.60M | $290.25M | $290.34M |
The company's financials show resilient growth, with revenue advancing from $5.04B in Q2 2024 to $5.17B in Q1 2025. Gross profit remained healthy with margins at 43% in Q1 2025 compared to 46% in Q2 2024. Operating income hit $453.00M last quarter, sustaining a consistent 9% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $453.00M. Net income dropped to $303.00M, while earnings per share reached $1.05. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan